Truist Securities Maintains Buy on Vericel, Raises Price Target to $54
Portfolio Pulse from Benzinga Newsdesk
Truist Securities analyst Samuel Brodovsky has maintained a Buy rating on Vericel (NASDAQ:VCEL) and increased the price target from $51 to $54.
March 01, 2024 | 1:44 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Truist Securities has maintained a Buy rating on Vericel and raised the price target from $51 to $54.
The increase in price target by a reputable analyst firm like Truist Securities typically signals a strong confidence in the company's future performance. This endorsement is likely to positively influence investor sentiment and potentially drive up the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100